Earnings History Data for Navidea Biopharmaceuticals, Inc. (NAVB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
21-03-2023	AH	4:00 PM ET (Mar 21)	NAVB	Navidea Biopharmaceuticals, Inc.	8.88	-0.11	0.00	-0.12	Navidea Biopharm GAAP EPS of -$0.11 [3/21/2023 4:04 PM]	0.3348	-0.01 (-1.50%)	0.32	-0.02 (-4.68%)	0.16 - 1.24	37,903	80,000	3,283
Navidea Biopharm GAAP EPS of -$0.11 [3/21/2023 4:04 PM]
14-11-2022	PM	4:00 PM ET (Nov 15)	NAVB	Navidea Biopharmaceuticals, Inc.	8.20	-0.25	0.00	-0.08	Navidea Biopharm GAAP EPS of -$0.25, revenue of $0.08M [11/14/2022 8:47 AM]	0.2795	0.0 (1.30%)	0.28	0.0 (0.00%)	0.21 - 1.42	42,621	40,000	937
CORRECTING and REPLACING Navidea Biopharmaceuticals Reports Third Quarter 2022 Financial Results [Nov-14-22 05:23PM] Navidea Biopharmaceuticals Reports Third Quarter 2022 Financial Results [Nov-14-22 08:00AM]
10-11-2021	AH	4:00 PM ET (Nov 10)	NAVB	Navidea Biopharmaceuticals, Inc.	44.94	-0.08	-0.09	-0.13	Navidea Biopharm EPS beats by $0.03 [11/10/2021 4:07 PM]	1.41	-0.03 (-2.08%)	1.49	0.05 (3.47%)	1.29 - 3.15	30,721	60,000	380
Navidea Biopharm EPS beats by $0.03 [11/10/2021 4:07 PM]
11-08-2021	AH	4:00 PM ET (Aug 11)	NAVB	Navidea Biopharmaceuticals, Inc.	51.86	-0.09	-0.09	-0.11		1.63	-0.07 (-4.12%)	1.69	-0.01 (-0.59%)	1.46 - 3.94	100,951	30,000	376
Navidea Biopharmaceuticals Reports Second Quarter 2021 Financial Results [Aug-11-21 04:01PM] Navidea Biopharma (NAVB) Reports Q2 Loss, Misses Revenue Estimates [Aug-11-21 05:15PM]
11-05-2021	AH	4:20 PM ET (May 11)	NAVB	Navidea Biopharmaceuticals, Inc.	46.28	-0.11	-0.08	-0.13	Navidea Biopharm EPS misses by $0.03, misses on revenue [5/11/2021 4:18 PM]	1.58	-0.05 (-3.07%)	1.69	0.06 (3.68%)	0.88 - 5.36	68,674	110,000	513
Navidea Bio reports NIH grant to evaluate Tc99m tilmanocept as a kidney imaging agent [5/11/2021 7:53 AM] Navidea Biopharm EPS misses by $0.03, misses on revenue [5/11/2021 4:18 PM] Navidea Q1 loss widens as revenue drops, R&D expenses rise [5/11/2021 5:25 PM] Navidea Biopharmaceuticals Announces NIH Grant Award to UC San Diego for Clinical Study Evaluating Tc99m Tilmanocept as a Kidney Imaging Agent [May-11-21 07:30AM] Navidea Biopharmaceuticals, Inc. to Host Earnings Call [May-11-21 03:15PM] Navidea Biopharmaceuticals Reports First Quarter 2021 Financial Results [May-11-21 04:01PM]
24-03-2021	AH	4:00 PM ET (Mar 24)	NAVB	Navidea Biopharmaceuticals, Inc.	63.81	-0.11	-0.10	-0.15	Navidea Biopharm EPS beats by $0.01, misses on revenue [3/24/2021 4:23 PM]	2.06	0.0 (0.00%)	2.04	-0.02 (-0.97%)	0.63 - 5.36	496,799	270,000	9,589
Navidea Biopharm EPS beats by $0.01, misses on revenue [3/24/2021 4:23 PM] Navidea Biopharmaceuticals, Inc. to Host Earnings Call [Mar-24-21 02:45PM] Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-24-21 04:21PM]
12-11-2020	AH		NAVB	Navidea Biopharmaceuticals, Inc.	58.16	-0.13	-0.08	-0.17	Navidea Biopharm EPS misses by $0.04, beats on revenue [11/12/2020 4:12 PM]	2.76	0.52 (23.21%)	2.80	0.56 (25.00%)	0.63 - 5.36	5,767,278	211,613	829,162

13-08-2020	AH	4:00 PM ET (Aug 13)	NAVB	Navidea Biopharmaceuticals, Inc.	71.76	-0.11	-0.10	-0.24	Navidea Biopharm EPS misses by $0.01, misses on revenue [8/13/2020 4:14 PM]	3.38	0.21 (6.62%)	3.98	0.81 (25.55%)	0.49 - 5.36	1,198,566	580,820	163,048

14-05-2020	AH	4:05 PM ET (May 14)	NAVB	Navidea Biopharmaceuticals, Inc.	19.65	-0.13	0.00	-0.24		1.10	0.14 (14.42%)	1.09	-0.01 (-0.91%)	0.49 - 1.81	491,599	112,929	1,900